Mark Engel
About
Mark Engel is from United States. Mark is currently Founder at Lysigen, located in Cayman Islands. Mark also works as Chairman, CEO at Precisio Biotix Therapeutics, a job Mark has held since Jul 2017. Another title Mark currently holds is Chairman at Phagelux AgriHealth. In Mark's previous role as a Former Founder, Chairman at Tiger Medical Group, Mark worked in until Jan 2013. Prior to joining Tiger Medical Group, Mark was a Former Founder, Chairman at Excel PharmaStudies and held the position of Former Founder, Chairman.
You can find Mark Engel's email at finalscout.com. FinalScout is a professional database with business professional profiles and company profiles.
Mark Engel's current jobs
Lysigen has developed a high through put lysin screening system (LysiThru) to create first and best in class lysins.
Precisio Biotix, through its subsidiaries, is creating multiple best or first in class biological antibacterials, with an emphasis on topical difficult to treat diseases or problems. More information on the pipelines of each subsidiary can be found at www.lysigen.com or www.precisiobiotix.com. Operations in US and Asia.
Phagelux AgriHealth creates phage-based solutions for crop sciences, food safety and animal health. R&D and manufacturing facilities located in China and USA.
Tianshi Capital is an early stage family office investor in life sciences.
Haoyisheng is a leading healthcare technology company in China.
Mark Engel's past jobs
Tiger Medical Group was a direct from factory to hospital system medical supplier with about 3000 products. Company was sold to a PE firm.
In 2009, Excel was sold to PPD. At the Time Excel was the largest clinical research organization in China.